Description

Technical Parameters

Liraglutide 2mg/bottle Core Introduction

Pharmaceutical -grade lyophilized powder | Glucagon-like peptide-1 (GLP-1) analogue

Chemical structure : 97% homologous to human GLP-1 analog, with a C16 fatty acid side chain

Molecular weight : approximately 3,751 Da

Purity : ≥98% (HPLC)

Specifications : 2 mg/vial (approximately 6 mg/mL)

Appearance : White freeze-dried powder

Solvent : 1mL bacteriostatic water

Core Effects

Liraglutide is a long-acting GLP-1 receptor agonist widely used in the treatment of type 2 diabetes, obesity management, and cardiovascular risk control due to its potent glucose-lowering and weight-loss properties and cardiovascular protective effects .

✅ Glucose-dependent hypoglycemic effect :

Stimulates insulin secretion : Promotes beta cells to release insulin only when blood sugar rises

Inhibit glucagon : Reduce liver glucose output and reduce fasting and postprandial blood sugar fluctuations

✅ Powerful weight management :

Central appetite suppressant : Acts on the hypothalamic satiety center to reduce food intake

Delayed gastric emptying : Prolongs satiety and reduces energy absorption

✅ Cardiovascular protection :

Improved endothelial function : Reduced risk of atherosclerosis

Hypertensive and lipid -regulating : Slightly lowers blood pressure and improves blood lipid profile

✅ Advantages :

Long-lasting effect : Half-life 13 hours, once daily dosing

Multiple benefits : blood sugar reduction, weight loss, and cardiovascular protection

Usage Protocol

1. Recombination method :

Draw 1mL of solvent into the syringe and slowly inject it along the wall of the bottle

Gently rotate to dissolve , do not shake violently

Storage after reconstitution : Refrigerate at 2-8°C and use within 30 days

2. Injection protocol :

Injection route : Subcutaneous injection (abdomen, thigh, upper arm)

Starting dose : 0.6 mg/day for 1 week

Increase dose : Increase by 0.6 mg per week until the maintenance dose is reached

Maintenance dose : 1.2-1.8 mg/day, maximum dose 3.0 mg/day

3. Treatment options :

Type 2 diabetes :

Use alone or in combination with other hypoglycemic drugs

Adjust dosage based on blood glucose monitoring results

Obesity Management :

Combining diet and exercise

BMI ≥ 30 kg/m² or ≥ 27 kg/m² with complications

Storage Guidelines

1. Unrestored :

Temperature : 2-8°C refrigerated, do not freeze

Humidity : Relative humidity ≤ 60%

Expiration date : 30 months (2-8°C)

2. Storage after reconstitution :

Use immediately : decreased stability after reconstitution

Store in refrigerator : 2-8°C for no more than 30 days

Avoid freezing : Freeze-thawing can damage protein structure

Why choose liraglutide ?

Strongly effective in lowering blood sugar and reducing weight , with sufficient clinical evidence

Cardiovascular protection , large-scale studies confirm cardiovascular and cerebrovascular benefits

Once a day , high medication compliance

Quality Assurance :

cGMP Manufacturing : Complies with Good Manufacturing Practices for Pharmaceuticals

Three-level quality control : full-process monitoring of raw materials, semi-finished products and finished products

Biopotency Assay : Ensure consistent activity across each batch of product

Professional Packaging :

Prefilled pens : convenient self-administration for patients

Cold chain transportation : 2-8°C temperature control throughout the entire process

Light protection : original packaging to protect from light and moisture

Conclusion

Liraglutide is an ideal drug for the management of type 2 diabetes and obesity , particularly suitable for glycemic control, weight management, and cardiovascular risk reduction . The recommended dose is 1.2-3.0 mg/day .

Need a personalized plan ?

We provide professional medical guidance to help you use the product safely and effectively!

Need anything, please contact us